Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Investigators developed a novel severity scoring system for age-related macular degeneration that can generate distinct scores for exudative and nonexudative AMD.

Cognition Therapeutics (CGTX) reported preclinical data this week at the Association for Research in Vision and Ophthalmology showing the ...

Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, reported preclinical data this week at the Association for Research in ...

End-of-Phase 2 meeting with FDA requested for Alzheimer's disease - - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC - - Two posters at ARVO describe zervimesine's ...

End-of-Phase 2 meeting with FDA requested for Alzheimer’s disease - - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC - - Two posters at ARVO describe zervimesine's ...

New research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need ...

"This is a new type of retinal prosthesis that has the potential to restore vision lost to retinal degeneration without requiring any kind of complicated surgery or genetic modification," says ...

A new study has shown that evidence of genetic susceptibility to schizophrenia can be found in the retina. This finding could help improve the early detection of the disorder. The retina is part ...

Just when you think you've seen it all, researchers claim to have developed a way for people to see a color the human eye has previously never seen before. They're calling this new shade 'Olo.

A new retinal stimulation technique called Oz enabled volunteers to see colours that lie beyond the natural range of human vision. Developed by researchers at UC Berkeley, Oz works by stimulating ...